NZ221647A - Di- and triblock copolymers comprising polyalkylene oxide block and a block comprising glycolic acid ester and trimethylene carbonate linkages; slow release drug delivery systems - Google Patents

Di- and triblock copolymers comprising polyalkylene oxide block and a block comprising glycolic acid ester and trimethylene carbonate linkages; slow release drug delivery systems

Info

Publication number
NZ221647A
NZ221647A NZ221647A NZ22164787A NZ221647A NZ 221647 A NZ221647 A NZ 221647A NZ 221647 A NZ221647 A NZ 221647A NZ 22164787 A NZ22164787 A NZ 22164787A NZ 221647 A NZ221647 A NZ 221647A
Authority
NZ
New Zealand
Prior art keywords
block
acid ester
drug delivery
delivery systems
glycolic acid
Prior art date
Application number
NZ221647A
Other languages
English (en)
Inventor
Donald James Casey
Louis Rosati
Peter Kendrick Jarrett
Original Assignee
American Cyanamid Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US06/903,797 external-priority patent/US4716203A/en
Priority claimed from US06/903,801 external-priority patent/US4882168A/en
Application filed by American Cyanamid Co filed Critical American Cyanamid Co
Publication of NZ221647A publication Critical patent/NZ221647A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G63/00—Macromolecular compounds obtained by reactions forming a carboxylic ester link in the main chain of the macromolecule
    • C08G63/64—Polyesters containing both carboxylic ester groups and carbonate groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
    • A61K9/204—Polyesters, e.g. poly(lactide-co-glycolide)

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Polyesters Or Polycarbonates (AREA)
  • Materials For Medical Uses (AREA)
NZ221647A 1986-09-05 1987-09-02 Di- and triblock copolymers comprising polyalkylene oxide block and a block comprising glycolic acid ester and trimethylene carbonate linkages; slow release drug delivery systems NZ221647A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/903,797 US4716203A (en) 1986-09-05 1986-09-05 Diblock and triblock copolymers
US06/903,801 US4882168A (en) 1986-09-05 1986-09-05 Polyesters containing alkylene oxide blocks as drug delivery systems

Publications (1)

Publication Number Publication Date
NZ221647A true NZ221647A (en) 1990-09-26

Family

ID=27129378

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ221647A NZ221647A (en) 1986-09-05 1987-09-02 Di- and triblock copolymers comprising polyalkylene oxide block and a block comprising glycolic acid ester and trimethylene carbonate linkages; slow release drug delivery systems

Country Status (13)

Country Link
EP (1) EP0258780B1 (enExample)
KR (1) KR880003985A (enExample)
AU (1) AU605172B2 (enExample)
BR (1) BR8704648A (enExample)
CA (1) CA1283988C (enExample)
DE (1) DE3786309T2 (enExample)
DK (1) DK462287A (enExample)
ES (1) ES2058081T3 (enExample)
FI (1) FI873840A7 (enExample)
GR (1) GR3008526T3 (enExample)
HU (1) HU205711B (enExample)
IL (1) IL83764A (enExample)
NZ (1) NZ221647A (enExample)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL9401703A (nl) * 1994-10-14 1996-05-01 Rijksuniversiteit Kauwgom.
US5702717A (en) * 1995-10-25 1997-12-30 Macromed, Inc. Thermosensitive biodegradable polymers based on poly(ether-ester)block copolymers
US5665428A (en) * 1995-10-25 1997-09-09 Macromed, Inc. Preparation of peptide containing biodegradable microspheres by melt process
DE19726412A1 (de) * 1997-06-21 1998-12-24 Merck Patent Gmbh Implantatmaterial mit einer Träger-Wirkstoff-Kombination
US6201072B1 (en) * 1997-10-03 2001-03-13 Macromed, Inc. Biodegradable low molecular weight triblock poly(lactide-co- glycolide) polyethylene glycol copolymers having reverse thermal gelation properties
US6117949A (en) * 1998-10-01 2000-09-12 Macromed, Inc. Biodegradable low molecular weight triblock poly (lactide-co-glycolide) polyethylene glycol copolymers having reverse thermal gelation properties
DE69829204T2 (de) * 1997-10-03 2005-12-15 Macromed Inc., Salt Lake City Biologisch abbaubare triblock-poly(lactide-co-glycolide)-polyethylenglycol-copolymere mit umgekehrter thermischer gelierung
US6004573A (en) * 1997-10-03 1999-12-21 Macromed, Inc. Biodegradable low molecular weight triblock poly(lactide-co-glycolide) polyethylene glycol copolymers having reverse thermal gelation properties
US7662409B2 (en) 1998-09-25 2010-02-16 Gel-Del Technologies, Inc. Protein matrix materials, devices and methods of making and using thereof
US7018645B1 (en) 2000-04-27 2006-03-28 Macromed, Inc. Mixtures of various triblock polyester polyethylene glycol copolymers having improved gel properties
JP4354700B2 (ja) 2001-03-23 2009-10-28 ガムリンク エー／エス 改良された保存寿命を有する被覆された分解性チューインガムおよびその調製方法
US20040180111A1 (en) * 2001-03-23 2004-09-16 Lone Andersen Degradable resin substitute for chewing gum
EP1408876A4 (en) 2001-06-22 2004-09-22 Durect Corp ZERO ORDER COAXIAL IMPLANTS WITH EXTENDED RELEASE
DE60320224T2 (de) 2002-02-15 2009-05-14 Nektar Therapeutics Al, Corp., Huntsville Hydrolytisch abbaubare polyalkylenoxid-polymere
WO2003092468A2 (en) 2002-04-29 2003-11-13 Gel-Del Technologies, Inc. Biomatrix structural containment and fixation systems and methods of use thereof
AU2003222310B2 (en) * 2002-05-03 2009-04-09 Janssen Pharmaceutica N.V. Polymeric microemulsions
US7649023B2 (en) 2002-06-11 2010-01-19 Novartis Ag Biodegradable block copolymeric compositions for drug delivery
CN104383554B (zh) 2002-09-06 2018-06-08 天蓝制药公司 用于传递治疗剂的以环糊精为基础的聚合物
ATE404072T1 (de) 2002-09-24 2008-08-15 Gumlink As Biologisch abbaubarer kaugummi enthaltend wenigstens ein biologish abbaubares polymer mit hochmolekularem gewicht
MXPA05002961A (es) 2002-09-24 2005-06-03 Gumlink As Goma de mascar que comprende al menos dos diferentes polimeros biodegradables.
DE60323055D1 (de) 2003-05-06 2008-10-02 Gumlinck As Methode zur Herstellung von Kaugummigranulat und komprimierten Kaugummiprodukten, sowie ein Kaugummigranuliersystem
DK1474995T3 (da) 2003-05-06 2013-02-18 Gumlink As Fremgangsmåde til fremstilling af tyggegummigranulater, et gummisammensætningsekstruder- og granuleringssystem og et tyggegummiprodukt
US8465537B2 (en) 2003-06-17 2013-06-18 Gel-Del Technologies, Inc. Encapsulated or coated stent systems
US8153591B2 (en) 2003-08-26 2012-04-10 Gel-Del Technologies, Inc. Protein biomaterials and biocoacervates and methods of making and using thereof
CA2548822C (en) 2003-12-08 2015-08-11 Gel-Del Technologies, Inc. Mucoadhesive drug delivery devices and methods of making and using thereof
US20080176958A1 (en) 2007-01-24 2008-07-24 Insert Therapeutics, Inc. Cyclodextrin-based polymers for therapeutics delivery
US11890371B2 (en) 2007-12-26 2024-02-06 Petvivo Holdings, Inc. Biocompatible protein-based particles and methods thereof
WO2010057177A2 (en) 2008-11-17 2010-05-20 Gel-Del Technologies, Inc. Protein biomaterial and biocoacervate vessel graft systems and methods of making and using thereof
EP2477985B1 (en) 2009-09-15 2018-11-07 BlueLink Pharmaceuticals, Inc. Crlx101 for use in the treatment of cancer
CN105797168A (zh) 2010-05-18 2016-07-27 天蓝制药公司 用于治疗自身免疫性疾病或其它疾病的组合物和方法
WO2014055493A1 (en) 2012-10-02 2014-04-10 Cerulean Pharma Inc. Methods and systems for polymer precipitation and generation of particles
JP2023536346A (ja) 2020-08-05 2023-08-24 エリプシーズ ファーマ リミテッド シクロデキストリン含有ポリマートポイソメラーゼ阻害剤コンジュゲートおよびｐａｒｐ阻害剤を用いた癌の処置

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3736646A (en) * 1971-10-18 1973-06-05 American Cyanamid Co Method of attaching surgical needles to multifilament polyglycolic acid absorbable sutures
US4047533A (en) * 1976-09-20 1977-09-13 American Cyanamid Company Absorbable surgical sutures coated with polyoxyethylene-polyoxypropylene copolymer lubricant
US4429080A (en) * 1982-07-01 1984-01-31 American Cyanamid Company Synthetic copolymer surgical articles and method of manufacturing the same
US4452973A (en) * 1982-11-12 1984-06-05 American Cyanamid Company Poly(glycolic acid)/poly(oxyethylene) triblock copolymers and method of manufacturing the same
US4438253A (en) * 1982-11-12 1984-03-20 American Cyanamid Company Poly(glycolic acid)/poly(alkylene glycol) block copolymers and method of manufacturing the same

Also Published As

Publication number Publication date
EP0258780A2 (en) 1988-03-09
HUT52945A (en) 1990-09-28
GR3008526T3 (enExample) 1993-10-29
EP0258780A3 (en) 1988-05-18
ES2058081T3 (es) 1994-11-01
DE3786309D1 (de) 1993-07-29
FI873840L (fi) 1988-03-06
IL83764A0 (en) 1988-02-29
BR8704648A (pt) 1988-04-26
DE3786309T2 (de) 1994-02-10
HU205711B (en) 1992-06-29
FI873840A7 (fi) 1988-03-06
AU7797087A (en) 1988-03-10
IL83764A (en) 1991-05-12
EP0258780B1 (en) 1993-06-23
DK462287A (da) 1988-03-06
DK462287D0 (da) 1987-09-04
CA1283988C (en) 1991-05-07
AU605172B2 (en) 1991-01-10
FI873840A0 (fi) 1987-09-04
KR880003985A (ko) 1988-05-31

Similar Documents

Publication Publication Date Title
NZ221647A (en) Di- and triblock copolymers comprising polyalkylene oxide block and a block comprising glycolic acid ester and trimethylene carbonate linkages; slow release drug delivery systems
NZ231579A (en) Aerosol formulation containing a medicament and tetrafluoroethane
ZA876635B (en) Polyesters containing alkylene oxide blocks as drug delivery systems
DE3372103D1 (en) Poly(glycolic acid)/poly(oxyethylene)triblock copolymers and method of manufacturing the same
NZ225394A (en) A tablet having improved bioadhesion to mucous membranes comprising a biopolymer and a polyol
AU8235591A (en) Poly(alkylene oxide) amino acid copolymers and drug carriers and charged copolymers based thereon
AU638768B2 (en) Pharmaceutical and cosmetic depigmentation compositions with a caffeic acid base
NZ216662A (en) Capsule made from polyalkylene glycol and poly(ethylene oxide)
IL84945A (en) Renin inhibiting peptidyl aminodiols and pharmaceutical compositions comprising them
NZ221306A (en) 2-component immunoadjuvant comprising a mycobacterial free immunoadjuvant oil and a polycationic polyelectrolyte immunoadjuvant and vaccines thereof
AU3511889A (en) Pyridonecarboxylic acids and antibacterial agents
IL84105A0 (en) 1-tertiary-alkyl-substituted naphthyridine-and quinoline-carboxylic acids and salts thereof and pharmaceutical compositions containing them
EP0584876A3 (en) Low diol polyalkylene oxide biologically active proteinaceous substances
NZ224046A (en) Hiv antigenic peptide fragments and their use
IL87800A0 (en) Dioxolane-2-carboxylic acids and pharmaceutical compositions comprising them
GB2224932B (en) Pharmaceutical solutions comprising cromoglycic acid and salbutamol
EP0410422A3 (en) A highly absorbable pharmaceutical composition
NZ225198A (en) Castanospermine esters and glycosides and pharmaceutical compostions
AU4675989A (en) Rare earth oxides and a process for their preparation
NZ227669A (en) Amino acid glycerides and pharmaceutical compositions thereof
AU6442290A (en) Recorded message delivery system
AU3470889A (en) Novel processes and products involving yttrium-alkaline earth-bismuth-copper oxides
IL92854A0 (en) Controlled release,low-dose aspirin formulation and its preparation
AU5125390A (en) Substituted (quinolin-2-yl-methoxy)phenyl-n,n'- sulphonylureas, processes for their preparation and their use in medicaments
GB2204790B (en) Pharmaceutical compositions comprising a quinoline dicarboxylic acid and an anticholinergic agent